The company, Moon Express, is aiming to win the $20 million Google Lunar X Prize competition and become a payload delivery company.
NYS Entity Status
NYS Filing Date
DECEMBER 20, 2013
NYS DOS ID#
LEGALINC CORPORATE SERVICES INC.
8857 ALEXANDER ROAD
BATAVIA, NEW YORK, 14020
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - KSI EXPRESS INC.
Around the Web
- Moon Express Sets Its Sights on Deliveries to the Moon and Beyond
By KENNETH CHANG - Wednesday Jul 12, 2017
- Delete Hate Speech or Pay Up, Germany Tells Social Media Companies
By MELISSA EDDY and MARK SCOTT - Friday Jun 30, 2017
A new law will impose fines on companies like Facebook and Twitter if they fail to swiftly remove illegal or hateful content on their platforms.
- The Culture Wars Have Come to Silicon Valley
By NICK WINGFIELD - Tuesday Aug 8, 2017
After Google fired an engineer who wrote an anti-diversity manifesto, the tech industry is under the microscope for penalizing dissenting opinions.
- Ryder Trucks Launches Campaign With 'Inc.'
Tuesday Sep 19, 2017
"The campaign underscores how truck owners are essentially dumping cash all over America's highways from all the hidden costs required in maintaining a private fleet," Ryder's Karen Jones tells"Marketing Daily."
- NY AG presses TransUnion, Experian for cybersecurity details
By DAVID KLEPPER, Associated Press - Tuesday Sep 19, 2017
ALBANY, N.Y. (AP) — New York Attorney General Eric Schneiderman is pressing TransUnion and Experian to explain what cybersecurity they have in place to protect sensitive consumer information following a recent breach at Equifax that exposed the data of 143 million Americans.In letters to executives at the two credit monitoring companies, the Democratic attorney general asked them to describe their existing security systems as well as what changes they've made since the Equifax cyberattack."The unprecedented data breach experienced by Equifax Inc.
- Considering the Side Effects of Drugmakers’ Money-Back Guarantees
By KATIE THOMAS and CHARLES ORNSTEIN - Monday Jul 10, 2017
The Trump administration is considering encouraging lowering drug costs through outcome-based contracts, but there is little evidence the approach works.